David-Alexandre Gros, Principal
Eledon Pharmaceuticals is a clinical-stage biotechnology company headquartered in Irvine, California, developing therapies to protect transplanted organs and reduce rejection. Its lead compound is tegoprubart, an anti-CD40L antibody. The company's team includes officers David-Alexandre Gros, Allan Kirk, Bryan Smith, and John McBride, as listed on its website and LLC filing.
Filed February 21, 2025 · Glastonbury, CT
Find new biotechnology businesses in Glastonbury, then launch a cold email campaign built for you.
Eledon Pharmaceuticals is a biotechnology business (Corp) registered on February 21, 2025 with the Connecticut Division of Corporations. The business is located in Glastonbury, Connecticut 06033. The filing lists David-Alexandre Gros as Principal.
It's getting views. Claim the page for free to control what your customers see.
We matched this business to its website and pulled the domain's registration (WHOIS) record. Domain age is one of the strongest signals that a filing is a truly new business and not a re-filing or paperwork change.
Filing timeline will be available soon.
Eledon Pharmaceuticals was registered as Corp on February 21, 2025 in Connecticut.
Eledon Pharmaceuticals is based in Glastonbury, CT, 06033.
Eledon Pharmaceuticals is classified as a biotechnology business (immunology / transplant therapies).
No EIN was found on file for Eledon Pharmaceuticals at the time of registration.
Based on the business category, these service providers typically target this type of business.
We find newly registered businesses, verify their contact details, and build the campaign. You review everything before anything sends.
Build My Campaign Free ›